PCDH20_Pcdh20 Inhibitors
The class of PCDH20 inhibitors, therefore, includes compounds that modulate the calcium concentration (like EGTA), affect the Rho kinase pathway (Y-27632), alter PI3K activity (Wortmannin), or disrupt Src kinase signaling (PP2). Other members of this class target the MAPK signaling pathway, including p38 (SB203580), JNK (SP600125), and MEK (PD98059). These inhibitors can lead to changes in cell shape, adhesion strength, and motility, which are critical for the proper function of PCDH20 in maintaining cell-cell contacts.
In addition to these, antagonists of other cadherin proteins, such as N-cadherin (ADH-1), can disrupt the balance of cell adhesion forces, indirectly affecting PCDH20. The broader cellular context is also considered with inhibitors like GM6001 that prevent matrix metalloproteinase activity, affecting the extracellular matrix and potentially PCDH20-mediated adhesion. Wnt/β-catenin signaling is another target, with XAV-939 stabilizing axin to promote β-catenin degradation, thereby impacting cadherin-catenin complexes to which PCDH20 may contribute. GSK-3β inhibition by SB-216763 also indirectly sustains β-catenin levels, impacting these complexes. Lastly, the heat shock protein HSP90, necessary for the stability and function of many proteins, can be targeted by geldanamycin, indirectly affecting PCDH20's role in adhesion. These inhibitors are representative of strategies to modify PCDH20 function indirectly by altering the cellular context in which it operates. By influencing signaling pathways, cytoskeletal dynamics, and extracellular interactions, these compounds can affect PCDH20's role in cell-cell adhesion, which is central to its function. The reliance on these indirect methods is based on the complexity of cadherin-mediated adhesion and the multitude of factors that contribute to its regulation. While the direct inhibition of PCDH20 remains unachieved, the chemicals listed offer insight into the diverse biological processes that can be modulated to influence the function of proteins like PCDH20.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
EGTA can chelate calcium ions, which are essential for cadherin-mediated cell adhesion. By depleting extracellular calcium, EGTA can inhibit the adhesion function of cadherins, including PCDH20. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinase (ROCK), which is implicated in regulating cytoskeletal dynamics and cell adhesion. Inhibition of ROCK can alter the cell shape and motility, thereby affecting PCDH20-mediated cell-cell interactions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in various cellular processes, including cell adhesion and migration. Inhibition of PI3K can disrupt signaling pathways that may indirectly affect PCDH20 functions. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases, which are involved in signal transduction pathways that regulate cell adhesion. PP2 can disrupt these pathways, potentially affecting PCDH20 interactions in cell-cell adhesion. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase, which is involved in the response to stress and differentiation. Inhibiting p38 MAPK can influence cellular processes and signaling that may indirectly modulate the activity of PCDH20. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
GM6001 is a broad-spectrum matrix metalloproteinase inhibitor that can affect extracellular matrix remodeling. By altering the extracellular environment, GM6001 can indirectly affect PCDH20-mediated cell adhesion. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 inhibits Wnt/β-catenin signaling by stabilizing axin, leading to β-catenin degradation. Since β-catenin is involved in cadherin-mediated adhesion complexes, XAV-939 can indirectly affect PCDH20 function by disrupting these complexes. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763 inhibits glycogen synthase kinase-3 beta (GSK-3β), a kinase that can phosphorylate β-catenin, leading to its degradation. By inhibiting GSK-3β, this compound can affect β-catenin levels and thereby indirectly influence PCDH20's role in cell adhesion. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can regulate cell proliferation, differentiation, and apoptosis. By inhibiting JNK, SP600125 can alter signaling pathways that may indirectly modulate the activity of PCDH20. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is upstream of ERK in the MAPK signaling pathway. Inhibition of MEK can affect cell signaling that indirectly influences PCDH20 function. | ||||||